These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 7004618

  • 1. Treatment of acute renal failure due to myeloma kidney.
    Bear RA, Cole EH, Lang A, Johnson M.
    Can Med Assoc J; 1980 Oct 18; 123(8):750-3. PubMed ID: 7004618
    [Abstract] [Full Text] [Related]

  • 2. Chronic dialysis in patients with multiple myeloma and renal failure: a worthwhile treatment.
    Iggo N, Palmer AB, Severn A, Trafford JA, Mufti GJ, Taube D, Parsons V.
    Q J Med; 1989 Oct 18; 73(270):903-10. PubMed ID: 2629022
    [Abstract] [Full Text] [Related]

  • 3. [Development and treatment of renal insufficiency in multiple myeloma].
    Mølby L, Hansen HH, Jensen EL.
    Ugeskr Laeger; 1994 Jul 25; 156(30):4343-7. PubMed ID: 8066935
    [Abstract] [Full Text] [Related]

  • 4. Severe renal failure in multiple myeloma.
    Cosio FG, Pence TV, Shapiro FL, Kjellstrand CM.
    Clin Nephrol; 1981 Apr 25; 15(4):206-10. PubMed ID: 7237869
    [Abstract] [Full Text] [Related]

  • 5. [Successful haemodialysis treatment of acute renal failure in a patient with multiple myeloma (author's transl)].
    Kopsa H, Schmidt P, Zazgornik J, Balcke P, Deutsch E.
    Med Klin; 1978 May 05; 73(18):668-70. PubMed ID: 651757
    [Abstract] [Full Text] [Related]

  • 6. [Survival of myeloma patients treated with dialysis].
    Martín Reyes G, Valera A, Frutos MA, Ramos B, Ordóñez V, López de Novales E.
    Nefrologia; 2003 May 05; 23(2):131-6. PubMed ID: 12778877
    [Abstract] [Full Text] [Related]

  • 7. Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant.
    Lee CK, Zangari M, Barlogie B, Fassas A, van Rhee F, Thertulien R, Talamo G, Muwalla F, Anaissie E, Hollmig K, Tricot G.
    Bone Marrow Transplant; 2004 Apr 05; 33(8):823-8. PubMed ID: 14767499
    [Abstract] [Full Text] [Related]

  • 8. Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: a review of 50 cases. Report of the Italien Renal Immunopathology Group.
    Pozzi C, Pasquali S, Donini U, Casanova S, Banfi G, Tiraboschi G, Furci L, Porri MT, Ravelli M, Lupo A.
    Clin Nephrol; 1987 Jul 05; 28(1):1-9. PubMed ID: 3621685
    [Abstract] [Full Text] [Related]

  • 9. [Acute and chronic renal failure in patients with myeloma].
    Biriukova LS, Volodiaeva EB, Fetisova EV, Pivnik AV, Margolin OV.
    Ter Arkh; 1999 Jul 05; 71(7):58-64. PubMed ID: 10481869
    [Abstract] [Full Text] [Related]

  • 10. [Plasmapheresis as a co-treatment in acute renal failure secondary to myeloma kidney].
    Levy F, Camarero Temiño V, Torres Torres G, Hijazi Prieto B.
    Nefrologia; 2009 Jul 05; 29(3):283-4. PubMed ID: 19554076
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of renal insufficiency in patients with multiple myeloma].
    Vulić D, Radlović O, Stanojcić A, Radmilović A, Rajić M.
    Srp Arh Celok Lek; 1996 Jul 05; 124 Suppl 1():53-5. PubMed ID: 9102930
    [Abstract] [Full Text] [Related]

  • 12. Plasmapheresis and hemodialysis in the treatment of acute renal failure in multiple myeloma.
    Kes P, Pecanić Z, Getaldić B.
    Acta Med Croatica; 1995 Jul 05; 49(1):39-42. PubMed ID: 7633177
    [Abstract] [Full Text] [Related]

  • 13. Renal failure in multiple myeloma. Pathogenesis and prognostic implications.
    Alexanian R, Barlogie B, Dixon D.
    Arch Intern Med; 1990 Aug 05; 150(8):1693-5. PubMed ID: 2383164
    [Abstract] [Full Text] [Related]

  • 14. Autologous stem cell transplantation in multiple myeloma: outcome in patients with renal failure.
    Knudsen LM, Nielsen B, Gimsing P, Geisler C.
    Eur J Haematol; 2005 Jul 05; 75(1):27-33. PubMed ID: 15946307
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure.
    Vigneau C, Ardiet C, Bret M, Laville M, Fiere D, Tranchand B, Fouque D.
    J Nephrol; 2002 Jul 05; 15(6):684-9. PubMed ID: 12495285
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.